The genetics of renal tumors in end-stage renal failure differs from those occurring in the general population

Journal of the American Society of Nephrology

Volumn 9, Issue 6, 1998, Pages 1045-1051

  Chudek, Jerzy ^a   Herbers, Jutta ^a   Wilhelm, Mónica ^a   Kenck, Christiane ^a   Bugert, Peter ^a   Ritz, Eberhard ^b   Waldman, Fred ^c   Kovacs, Gyula ^a,b  

^a Laboratory of Molecular Oncology   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTIDINE; PROTEIN P53; RNA;

ADULT; AGED; ARTICLE; CHROMOSOME 3P; CHROMOSOME DELETION; CHROMOSOME FRAGILE SITE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; GENE; HUMAN; HUMAN TISSUE; HYBRIDIZATION; KIDNEY FAILURE; KIDNEY TUMOR; MALE; NEPHRECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRISOMY; TUMOR SUPPRESSOR GENE;

EID: 0031779491     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Matson MA, Cohen EP: Acquired cystic kidney disease: Occurrence, prevalence and renal cancers. Medicine 69: 217-226, 1990
2. Marple JT, MacDougall M: Development of malignancy in the end-stage renal disease patient. Semin Nephrol 13: 306-314, 1993
3. Troung LD, Krishnan B, Barrios R, Suki WN: Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis 26: 1-12, 1995
4. Ishikawa I: Acquired cystic disease: Mechanisms and manifestations. Semin Nephrol 11: 671-684, 1991
5. Kovacs G: Molecular cytogenetics of renal cell tumors. Adv Cancer Res 62: 89-124, 1993
6. Ishikawa I, Kovacs G: High incidence of papillary renal cell tumors in patients on chronic hemodialysis. Histopathology 22: 135-139, 1993
7. Ishikawa I, Shikura N, Ozaki M: Papillary renal cell carcinoma with numeric changes of chromosomes in a long-term hemodialysis patient: A karyotype analysis. Am J Kidney Dis 21: 553-556, 1993
8. Hughson MD, Meloni AM, Silva FG, Sandberg AA: Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: Cytogenetic and molecular genetic findings. Cancer Genet Cytogenet 89: 65-68, 1996
9. Renshaw AA, Maurici D, Fletcher JA: Papillary renal cell carcinoma with rare papillae histologically resembling collecting duct carcinoma. J Urol Pathol 5: 65-74, 1996
10. Hughson MD, Schmidt L, Zbar B, Daugherty S, Meloni AM, Silva FG, Sandberg AA: Renal cell carcinoma of end-stage renal disease: A histopathologic and molecular genetic study. J Am Soc Nephrol 7: 2461-2468, 1996
11. Cengiz K, Block A-MW, Hossfeld DK, Anthone R, Anthone S, Sandberg AA: Sister chromatide exchange and chromosome abnormalities in uremic patients. Cancer Genet Cytogenet 36: 55-67, 1988
12. Malachi T, Zevin D, Gafter U, Chagnac A, Slor H, Levi J: DNA repair and recovery of RNA synthesis in uremic patients. Kidney Int 44: 385-389, 1993
13. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K: The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597, 1996
14. Bugert P, Wilhelm M, Kovacs G: FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Genes Chromosomes Cancer 20: 9-15, 1997
15. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Störkel S, ven den Berg E, Zbar B: The Heidelberg classification of renal cell tumours [Editorial]. J Pathol 183: 131-133, 1997
16. Bugert P, Kovacs G: Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am J Pathol 149: 2081-2088, 1996
17. Nakahori Y, Hamano K, Iwaya M, Nakagome Y: Sex identification by polymerase chain reaction using X-Y homologous primers. Am J Med Genet 39: 472-473, 1991
18. Speicher MR, duManoir S, Schrock E, Holtgreve-Grez H, Schoel B, Lengauer C, Cremer T, Ried T: Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridisation after universal DNA amplification. Hum Mol Genet 2: 1907-1914, 1994
19. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Gray JW, Pinkel D, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridisation. Proc Natl Acad Sci USA 91: 2156-2160, 1994
20. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM: Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6: 1997-2003, 1991
21. Ebert M, Munehiro Y, Friess H, Büchler MW, Korc M: Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 54: 5775-5778, 1994
22. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E: Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 189: 227-232, 1992
23. Schmidt L, Duh FM, Chen F: Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16: 68-73, 1997
24. Gnarra JR, Tory K, Schmidt L, Wie MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzati R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM: Mutation of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7: 85-90, 1994
25. Thoenes W, Störkel S, Rumpelt HJ: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas): The basic cytological and histomorphological elements and their use for diagnostics. Pathol Res Pract 181: 125-143, 1986
26. Bugert P, Gaul C, Weber K, Herbers J, Akhtar M, Ljungberg B, Kovacs G: Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest 76: 203-208, 1997
27. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Silva FG: Tubular atrophy in the end-stage kidney: A lectin and immunohistochemical study. Hum Pathol 25: 22-28, 1994
28. Klotz LH, Kulkarni C, Mills G: End stage renal disease serum contains a specific renal cell growth factor. J Urol 145: 156-160, 1991
29. Ye M, Grantham JJ: The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease. N Engl J Med 329: 310-313, 1993
30. Mangoo-Karim R, Uchic ME, Grant M, Shumate WA, Calvet JP, Park CH, Grantham JJ: Renal epithelial fluid secretion and cyst growth: The role of cyclic AMP. FASEB J 3: 2629-2632, 1989
31. Moskowith DW, Bonar SL, Marcus MD, dayman RV, Avner EC: Epidermal growth factor (EGF) content of human and mouse (CPK) renal cysts. Am J Kidney Dis 14: 435-436, 1989
32. Herrera GA: C-erbB-2 amplification in cystic renal disease. Kidney Int 40: 509-513, 1991
33. Sozzi G, Sard L, De Gregorio L, Marchetti A, Musso K, Buttitta F, Tornielli S, Pellegrini S, Veronese ML, Manenti G, Incarbone M, Chella A, Angeletti CA, Pastorino U, Huebner K, Bevilaqua G, Pilotti S, Croce CM, Pierotti MA: Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res 57: 2121-2123, 1997